Abstract
Desmoid tumors are fibrous neoplasms that are infiltrative and locally aggressive. Although they are histologically benign with negligible metastatic potential, recurrence after surgical resection is common. Pharmacotherapy and radiation treatment have been utilized when surgery has been considered unsuitable. Since April 2003, we have used radiofrequency ablation to treat five desmoid tumors in four patients. Complications were seen in two patients; one patient had cellulitis and another had soft tissue necrosis. Clinical follow-up was available for all four patients and ranged from 4–68 months (mean 30 months). No recurrences were detected.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Okuno S. The enigma of desmoid tumors. Curr Treat Options Oncol. 2006;7:438–43.
Lewis JJ, Boland PJ, Leung DH, Woodruff JM, Brennan MF. The enigma of desmoid tumors. Ann Surg. 1999;229:866–72.
Janinis J, Patriki M, Vini L, Aravantinos G, Whelan JS. The pharmacological treatment of aggressive fibromatosis: a systematic review. Ann Oncol. 2003;14:181–90.
Zlotecki RA, Scarborough MT, Morris CG, et al. External beam radiotherapy for primary and adjuvant management of aggressive fibromatosis. Int J Radiat Oncol Biol Phys. 2002;54:177–81.
Rosenthal DI, Alexander A, Rosenberg AE, Springfield D. Ablation of osteoid osteomas with a percutaneously placed electrode: a new procedure. Radiology. 1992;183:29–33.
Callstrom MR, Atwell TD, Charboneau JW, et al. Painful metastases involving bone: percutaneous image-guided cryoablation—prospective trial interim analysis. Radiology. 2006;241:572–80.
Farrell MA, Charboneau WJ, DiMarco DS, Chow GK, Zincke H, Callstrom MR, et al. Imaging-guided radiofrequency ablation of solid renal tumors. AJR Am J Roentgenol. 2003;180:1509–13.
Curley SA, Izzo F, Ellis LM, Nicolas Vauthey J, Vallone P. Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis. Ann Surg. 2000;232:381–91.
Rybak LD, Rosenthal DI, Wittig JC. Chondroblastoma: radiofrequency ablation—alternative to surgical resection in selected cases. Radiology. 2009;251:599–604.
Corby RR, Stacy GS, Peabody TD, Dixon LB. Radiofrequency ablation of solitary eosinophilic granuloma of bone. AJR Am J Roentgenol. 2008;190:1492–4.
Roxsenthal DI, Treat ME, Mankin HJ, et al. Treatment of epithelioid hemangioendothelioma of bone using a novel combined approach. Skeletal Radiol. 2001;30:219–22.
Neeman Z, Patti JW, Wood BJ. Percutaneous radiofrequency ablation of chordoma. AJR Am J Roentgenol. 2002;179:1330–2.
Hesse E, Rosenthal H, Bastian L. Radiofrequency ablation of a tumor causing oncogenic osteomalacia. N Engl J Med. 2007;357:422–4.
Tsz-Kan T, Man-Kwong C, Shu Shang-Jen J, Ying-Lee L, Wai Man-Wah A, Hon- Shing F. Radiofrequency ablation of recurrent fibromatosis. J Vasc Interv Radiol. 2007;18:147–50.
Lundskog J. Heat and bone tissue: an experimental investigation of the thermal properties of bone and threshold levels for thermal injury. Scand J Plast Reconstr Surg. 1972;9:1–80.
Goetz MP, Callstrom MR, Charboneau JW, Farrell MA, Maus TP, Welch TJ, et al. Percutaneous image-guided radiofrequency ablation of painful metastases involving bone: a multicenter study. J Clin Oncol. 2004;22:300–6.
McGahan JP, Dodd GD. Radiofrequency ablation of the liver: current status. AJR Am J Roentgenol. 2001;176:3–16.
Wood TF, Rose DM, Chung M, Allegra DP, Foshag LJ, Bilchik AJ. Radiofrequency ablation of 231 unresectable hepatic tumors: indications, limitations, and complications. Ann Surg Oncol. 2000;7:593–600.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ilaslan, H., Schils, J., Joyce, M. et al. Radiofrequency ablation: another treatment option for local control of desmoid tumors. Skeletal Radiol 39, 169–173 (2010). https://doi.org/10.1007/s00256-009-0807-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00256-009-0807-6